Vitamin deficiency vertigo. Vitamin D Supplementation for Benign Paroxysmal Positional Vertigo: Impact on Intensity and Recurrence
How does vitamin D supplementation affect benign paroxysmal positional vertigo. What is the relationship between vitamin D deficiency and BPPV symptoms. Can vitamin D supplementation reduce the recurrence rate of BPPV. How does vitamin D influence muscle function and balance in BPPV patients. What are the long-term outcomes of vitamin D supplementation for BPPV management.
Understanding Benign Paroxysmal Positional Vertigo (BPPV)
Benign Paroxysmal Positional Vertigo (BPPV) is a common vestibular disorder characterized by brief episodes of vertigo triggered by changes in head position. This condition can significantly impact a person’s quality of life and daily activities. BPPV occurs when tiny calcium crystals, known as otoconia, become dislodged from their normal position in the inner ear and migrate into the semicircular canals. This displacement causes abnormal stimulation of the vestibular system, resulting in the characteristic symptoms of vertigo, dizziness, and imbalance.
The prevalence of BPPV increases with age, and it is more common in women than in men. While the exact cause of BPPV is often unknown, several risk factors have been identified, including head trauma, inner ear infections, and prolonged bed rest. Recent studies have also suggested a potential link between vitamin D deficiency and the development and recurrence of BPPV.
Key Symptoms of BPPV
- Sudden onset of vertigo with changes in head position
- Sensation of spinning or room movement
- Nausea and vomiting
- Loss of balance or unsteadiness
- Nystagmus (involuntary eye movements)
Is BPPV a serious condition? While BPPV is generally not life-threatening, it can significantly impact a person’s quality of life and increase the risk of falls, especially in older adults. Proper diagnosis and management are crucial for minimizing symptoms and preventing complications.
The Role of Vitamin D in Vestibular Function
Vitamin D is a crucial nutrient that plays a vital role in various physiological processes, including bone metabolism, muscle function, and calcium homeostasis. Recent research has highlighted the potential importance of vitamin D in maintaining vestibular health and preventing balance disorders such as BPPV.
The vestibular system, located in the inner ear, is responsible for maintaining balance and spatial orientation. Vitamin D receptors have been identified in the inner ear, suggesting a direct relationship between vitamin D levels and vestibular function. Additionally, vitamin D is essential for calcium metabolism, which is crucial for the proper formation and maintenance of otoconia in the inner ear.
Mechanisms of Vitamin D Action in the Vestibular System
- Regulation of calcium homeostasis in the inner ear
- Maintenance of otoconia structure and function
- Support of vestibular hair cell health
- Modulation of inflammatory responses in the inner ear
- Enhancement of muscle strength and balance
How does vitamin D deficiency affect vestibular function? Vitamin D deficiency may lead to impaired calcium metabolism, weakened otoconia, and reduced muscle strength, potentially increasing the risk of BPPV development and recurrence.
Prevalence of Vitamin D Deficiency in BPPV Patients
Several studies have investigated the prevalence of vitamin D deficiency among patients with BPPV. A significant body of evidence suggests that individuals with BPPV are more likely to have low serum vitamin D levels compared to the general population. This association has been observed across various age groups and geographic locations.
One notable study by Jeong et al. (2013) found that serum vitamin D levels were significantly lower in patients with idiopathic BPPV compared to healthy controls. The researchers observed a negative correlation between serum vitamin D levels and the recurrence rate of BPPV, suggesting that vitamin D deficiency may be a risk factor for both the development and recurrence of the condition.
Factors Contributing to Vitamin D Deficiency in BPPV Patients
- Decreased sun exposure due to reduced outdoor activity
- Age-related decline in vitamin D synthesis
- Inadequate dietary intake of vitamin D
- Impaired absorption or metabolism of vitamin D
- Comorbid conditions affecting vitamin D status
Does the severity of vitamin D deficiency correlate with BPPV symptoms? Some studies have suggested a potential relationship between the degree of vitamin D deficiency and the severity of BPPV symptoms, but more research is needed to establish a definitive correlation.
Impact of Vitamin D Supplementation on BPPV Intensity
The influence of vitamin D supplementation on the intensity of BPPV symptoms has been a subject of growing interest in recent years. Several clinical studies have investigated the potential benefits of vitamin D supplementation in managing BPPV and reducing symptom severity.
A longitudinal clinical study by Talaat et al. (2015) examined the effect of vitamin D supplementation on BPPV recurrence rates. The researchers found that treating severe vitamin D deficiency in BPPV patients led to a significant reduction in the recurrence rate of the condition. This suggests that vitamin D supplementation may not only alleviate symptoms but also help prevent future episodes of vertigo.
Potential Mechanisms of Vitamin D Supplementation in BPPV Management
- Improvement of calcium metabolism in the inner ear
- Enhancement of otoconia stability
- Reduction of inflammation in the vestibular system
- Strengthening of muscles involved in balance and posture
- Modulation of neurotransmitter function in the vestibular pathway
Can vitamin D supplementation replace traditional BPPV treatments? While vitamin D supplementation shows promise in managing BPPV, it should be considered as a complementary approach rather than a replacement for established treatments such as canalith repositioning maneuvers.
Vitamin D and Muscle Function in BPPV Patients
The relationship between vitamin D and muscle function is particularly relevant in the context of BPPV management. Vitamin D plays a crucial role in maintaining muscle strength, balance, and overall physical performance. These factors are essential for preventing falls and minimizing the impact of BPPV symptoms on daily activities.
Research by Rejnmark (2011) and Muir et al. (2011) has demonstrated that vitamin D supplementation can improve muscle strength, gait, and balance in older adults. Given that BPPV is more prevalent in the elderly population, addressing vitamin D deficiency may have multiple benefits beyond managing vertigo symptoms.
Effects of Vitamin D on Muscle Function
- Increased muscle protein synthesis
- Enhanced calcium handling in muscle cells
- Improved neuromuscular coordination
- Reduced inflammation and oxidative stress in muscles
- Modulation of muscle fiber composition
How does improved muscle function benefit BPPV patients? Enhanced muscle strength and balance can help individuals with BPPV maintain stability during vertigo episodes, reduce the risk of falls, and improve overall quality of life.
Long-term Outcomes of Vitamin D Supplementation in BPPV
Assessing the long-term outcomes of vitamin D supplementation in BPPV patients is crucial for understanding its potential as a preventive and therapeutic strategy. While short-term studies have shown promising results, more longitudinal research is needed to fully elucidate the long-term benefits of vitamin D supplementation in managing BPPV.
A study by Bischoff-Ferrari et al. (2009) demonstrated that vitamin D supplementation could reduce the risk of falls in older adults. Given the association between BPPV and an increased risk of falls, this finding suggests that long-term vitamin D supplementation may have broader implications for overall health and safety in BPPV patients.
Potential Long-term Benefits of Vitamin D Supplementation in BPPV
- Reduced frequency and severity of BPPV episodes
- Improved vestibular function and balance
- Decreased risk of falls and related injuries
- Enhanced overall physical performance
- Improved quality of life and reduced healthcare utilization
What is the optimal duration of vitamin D supplementation for BPPV management? The ideal duration of vitamin D supplementation may vary depending on individual factors such as baseline vitamin D levels, age, and comorbid conditions. Long-term monitoring and personalized treatment plans are essential for maximizing the benefits of vitamin D supplementation in BPPV patients.
Integrating Vitamin D Supplementation into BPPV Treatment Protocols
As evidence supporting the role of vitamin D in BPPV management continues to grow, healthcare providers are increasingly considering the integration of vitamin D supplementation into standard treatment protocols. This approach aims to address both the immediate symptoms of BPPV and the underlying factors that may contribute to its development and recurrence.
Combining vitamin D supplementation with established treatments such as the Epley maneuver may offer a more comprehensive approach to BPPV management. Hilton and Pinder (2004) demonstrated the effectiveness of the Epley maneuver in treating BPPV, while recent studies suggest that vitamin D supplementation could enhance the long-term outcomes of these repositioning techniques.
Considerations for Integrating Vitamin D Supplementation
- Assessment of baseline vitamin D levels in BPPV patients
- Determination of appropriate vitamin D dosage and duration
- Monitoring of serum vitamin D levels during treatment
- Evaluation of potential interactions with other medications
- Patient education on the importance of vitamin D in vestibular health
How can healthcare providers determine the optimal vitamin D supplementation regimen for BPPV patients? Individualized treatment plans based on factors such as age, comorbidities, and baseline vitamin D levels are essential for maximizing the benefits of supplementation while minimizing potential risks.
Future Directions in Vitamin D and BPPV Research
The growing body of evidence supporting the relationship between vitamin D and BPPV has opened up new avenues for research in this field. Future studies are needed to further elucidate the mechanisms underlying this association and to optimize treatment strategies incorporating vitamin D supplementation.
One area of interest is the potential role of vitamin D in preventing BPPV in high-risk populations. Heidari et al. (2012) highlighted the seasonal variations in serum vitamin D levels, which may have implications for BPPV incidence and management. Understanding these temporal patterns could inform preventive strategies and guide the timing of vitamin D supplementation.
Promising Areas for Future Research
- Genetic factors influencing vitamin D metabolism in BPPV patients
- The impact of vitamin D on vestibular hair cell regeneration
- The role of vitamin D in modulating inflammatory responses in the inner ear
- Optimization of vitamin D supplementation protocols for BPPV prevention
- The potential synergistic effects of vitamin D with other micronutrients in BPPV management
What novel approaches could be explored in vitamin D and BPPV research? Investigating the use of vitamin D analogs or combination therapies targeting multiple aspects of vestibular function may yield new insights into BPPV treatment and prevention strategies.
In conclusion, the growing body of evidence supporting the role of vitamin D in BPPV management offers promising avenues for improving patient outcomes. By addressing vitamin D deficiency and incorporating supplementation into treatment protocols, healthcare providers may be able to reduce the intensity and recurrence of BPPV symptoms while enhancing overall vestibular health. As research in this field continues to evolve, a more comprehensive understanding of the relationship between vitamin D and BPPV will likely lead to more effective and personalized treatment strategies for patients suffering from this common vestibular disorder.
Influence of supplemental vitamin D on intensity of benign paroxysmal positional vertigo: A longitudinal clinical study
1. Heidari B, Heidari P, Samari E, Jalali MR. Frequency of vitamin D deficiency in common musculoskeletal conditions. J Babol Univ Med Sci. 2014;16:7–15. [in Persian] [Google Scholar]
2. Heidari B, Heidari P, Hajian-Tilaki K. High prevalence of vitamin D deficiency in women presenting to rheumatology clinic in north of Iran: An inverse relation with age. J Women’s Health Care. 2013;2:123. [Google Scholar]
3. Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I. Caspian J Intern Med. 2011;2:205–12. [PMC free article] [PubMed] [Google Scholar]
4. Heidari B. Muscle strength, vitamin D deficiency and knee osteoarthritis. J Babol Univ Med Sci. 2012;14:84–91. [Google Scholar]
5. Heidari B. Knee osteoarthritis diagnosis, treatment and associated factors of progression: Part II. Casp J Intern Med. 2011;2:249–55. [PMC free article] [PubMed] [Google Scholar]
6. Heidari B, Heidari P, Tilaki KH. Relationship between unexplained arthralgia and vitamin D deficiency: a case control study. Acta Med Iran. 2014;52:400–5. [PubMed] [Google Scholar]
7. Heidari B, Javadian Y, Babaei M, Yousef Ghahari B. Restorative effect of vitamin D deficiency on knee pain and quadriceps muscle strength in knee osteoarthritis. Acta Med Iran. 2015;53:460–70. [PubMed] [Google Scholar]
8. Heidari B, Monadi M, Asgharpour M, et al. Efficiency of supplemental vitamin D in patients with chronic obstructive pulmonary disease. Br J Med Med Res. 2014;4:3031–41. [Google Scholar]
9. Silva C, Amorim AM, Paiva A. Benign paroxysmal positional vertigo–a review of 101 cases. Acta Otorrinolaringol Esp. 2015;66:205–9. [PubMed] [Google Scholar]
10. Lopez-Escamez JA, Gamiz MJ, Fernandez-Perez A, Gomez-Fiñana M. Long-term outcome and health-related quality of life in benign paroxysmal positional vertigo. Eur Arch Otorhinolaryngol. 2005;262:507–11. [PubMed] [Google Scholar]
11. Iwasaki S, Yamasoba T. Dizziness and Imbalance in the Elderly: Age-related Decline in the Vestibular System. Aging Dis. 2014;6:38–47. [PMC free article] [PubMed] [Google Scholar]
12. Rejnmark L. Effects of vitamin D on muscle function and performance: a review of evidence from randomized controlled trials. Ther Adv Chronic Dis. 2011;2:25–37. [PMC free article] [PubMed] [Google Scholar]
13. Muir SW, Montero-Odasso M. Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2011;59:2291–300. [PubMed] [Google Scholar]
14. Hilton M, Pinder D. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev. 2004;2:CD003162. [PubMed] [Google Scholar]
15. Nunez RA, Cass SP, Furman JM. Short- and long-termoutcomes of canalith repositioning for benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 2000;122:647–52. [PubMed] [Google Scholar]
16. West N, Hansen S, Møller MN, Bloch SL, Klokker M. Repositioning chairs in benign paroxysmal positional vertigo: implications and clinical outcome. Eur Arch Otorhinolaryngol. 2015 Mar 7; [Epub ahead of print] [PubMed] [Google Scholar]
17. Heidari B, Haji Mirghassemi MB. Seasonal variations in serum vitamin D according to age and sex. Caspian J Intern Med. 2012;3:535–40. [PMC free article] [PubMed] [Google Scholar]
18. Talaat HS, Kabel AH, Khaliel LH, Abuhadied G, El-Naga HA, Talaat AS. Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency. Auris Nasus Larynx. 2015 Sep 16; pii: S0385-8146(15)00203-5. doi: 10.1016/j.anl.2015.08.009. [Epub ahead of print] [PubMed] [Google Scholar]
19. Jeong SH, Kim JS, Shin JW, et al. Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J Neurol. 2013;260:832–8. [PubMed] [Google Scholar]
20. Suzuki T. Frontiers in vitamin D; basic research and clinical application Vitamin D and falls. Clin Calcium. 2011;21:71–9. [PubMed] [Google Scholar]
21. Mastaglia SR, Seijo M, Muzio D, et al. Effect of vitamin D nutritional status on muscle function and strength in healthy women aged over sixty-five years. J Nutr Health Aging. 2011;15:349–54. [PubMed] [Google Scholar]
22. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692. [PMC free article] [PubMed] [Google Scholar]
23. Boersma D, Demontiero O, Mohtasham Amiri Z, et al. Vitamin D status in relation to postural stability in the elderly. J Nutr Health Aging. 2012;16:270–5. [PubMed] [Google Scholar]
24. Cangussu LM, Nahas-Neto J, Orsatti CL, et al. Effect of isolated vitamin D supplementation on the rate of falls and postural balance in postmenopausal women fallers: a randomized, double-blind, placebo-controlled trial. Menopause. 2015 Nov 2; [Epub ahead of print] [PubMed] [Google Scholar]
25. Parham K, Leonard G, Feinn RS, et al. Prospective clinical investigation of the relationship between idiopathic benign paroxysmal positional vertigo and bone turnover: a pilot study. Laryngoscope. 2013;123:2834–9. [PubMed] [Google Scholar]
26. Talaat HS, Abuhadied G, Talaat AS, Abdelaal MS. Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo. Eur Arch Otorhinolaryngol. 2015;272:2249–53. [PubMed] [Google Scholar]
27. Yu S, Liu F, Cheng Z, Wang Q. Association between osteoporosis and benign paroxysmal positional vertigo: a systematic review. BMC Neurol. 2014;14:110. [PMC free article] [PubMed] [Google Scholar]
28. Heidari B, Heidari P, Nourooddini HG, Hajian-Tilaki KO. Relationship between parity and bone mass in postmenopausal women according to number of parities and age. J Reprod Med. 2013;58:389–94. [PubMed] [Google Scholar]
29. Heidari B, Hoshmand S, Hajian K, Heidari P. Comparing bone mineral density in postmenopausal women with and without vertebral fracture and its value in recognizing high-risk individuals. East Mediterr Health J. 2010;16:868–73. [PubMed] [Google Scholar]
30. Heidari B, Javadian Y, Monadi M, Dankob Y, Firouzjahi A. Vitamin D status and distribution in patients with chronic obstructive pulmonary disease versus healthy controls. Caspian J Intern Med. 2015;6:93–7. [PMC free article] [PubMed] [Google Scholar]
31. Hajian-Tilaki K, Heidari B, Firouzjahi A, et al. Prevalence of metabolic syndrome and the association with socio-demographic characteristics and physical activity in urban population of Iranian adults: a population-based study. Diabetes Metab Syndr. 2014;8:170–6. [PubMed] [Google Scholar]
32. Prasad P, Kochhar A. Interplay of vitamin D and metabolic syndrome: A review. Diabetes Metab Syndr. 2015 Mar 6; pii: S1871-4021(15)00027-2. doi: 10.1016/j.dsx.2015 .02.014. [Epub ahead of print] [PubMed] [Google Scholar]
33. Hajian-Tilaki K, Heidari B. Prevalence of obesity, central obesity and the associated factors in urban population aged 20-70 years, in the north of Iran: a population-based study and regression approach. Obes Rev. 2007;8:3–10. [PubMed] [Google Scholar]
34. Hajian-Tilaki K, Heidari B. Childhood obesity, overweight, sociodemographic and life style determinants among preschool children in Babol, Northern Iran. Iran Public Health. 2013;42:1283–91. [PMC free article] [PubMed] [Google Scholar]
35. Hajian-Tilaki K, Heidari B. Prevalence of overweight and obesity and their association with physical activity pattern among Iranian adolescents aged 12-17 years. Public Health Nutr. 2012;15:2246–52. [PMC free article] [PubMed] [Google Scholar]
36. Waringhoff JC, Bayer O, Ferrari U, Straube A. Co-morbidities of vertiginous disease. BMC Neurol. 2009;9:29. [PMC free article] [PubMed] [Google Scholar]
37. Yamanka T, Fukuda T, Shirota S, et al. The prevalence and characteristics of metabolic syndrome in patients with vertigo. Plos One. 2013;8:e80176. [PMC free article] [PubMed] [Google Scholar]
Two Common Nutrients Might Keep Vertigo at Bay
WEDNESDAY, Aug. 5, 2020 (HealthDay News) — Taking in extra vitamin D plus calcium might cut your odds of getting a debilitating form of vertigo, new research shows.
The Korean study focused on benign paroxysmal positional vertigo (BPPV), a sudden spinning sensation that’s commonly triggered by changing your head position. According to the study authors, about 86% of people who have this type of vertigo find that it affects their life, even resulting in missed days at work.
Often, the condition can be remedied by undergoing a specific type of head movement under a doctor’s supervision, according to researcher Dr. Ji-Soo Kim, of Seoul National University College of Medicine.
But the new findings now suggest that for folks with BPPV, “taking a supplement of vitamin D and calcium is a simple, low-risk way to prevent vertigo from recurring,” he said in a news release from the American Academy of Neurology.
Kim added that the treatment “is especially effective if you have low vitamin D levels to begin with.”
One U.S. expert said the study adds to prior data supporting the therapy.
The study “represents the best evidence to date that a simple over-the-counter treatment of this common condition affecting adults over the age of 50 is safe and effective,” said Dr. Anthony Geraci. He directs neuromuscular medicine for Northwell Health in Great Neck, N.Y.
In their study, Kim’s team recruited more than 900 people with BPPV. Participants were divided into two groups. In the first group, those with low vitamin D levels (below 20 nanograms per milliliter) were given supplements with 400 international units of vitamin D and 500 milligrams of calcium, twice daily, while those with healthier vitamin D levels (equal to or greater than 20 ng/mL) were not given supplements.
The second group was not given supplements regardless of their vitamin D levels.
The result: People taking the supplements experienced a 24% reduction in their rate of vertigo compared with those not taking supplements, the researchers found.
The greatest benefit was seen in those who were more deficient in vitamin D to begin with. People whose vitamin D levels were lower than 10 ng/mL saw a 45% reduction in vertigo recurrence, while those with vitamin D levels of 10 to 20 ng/mL saw only a 14% reduction, the researchers found.
In all, 38% of people who took vitamin D/calcium experienced another episode of vertigo, compared with 47% of those who weren’t taking them.
“Our results are exciting because, so far, going to the doctor to have them perform head movements has been the main way we treat benign paroxysmal positional vertigo,” Kim said. “Our study suggests an inexpensive, low-risk treatment like vitamin D and calcium tablets may be effective at preventing this common, and commonly recurring, disorder.”
Geraci noted there are already good reasons to get more vitamin D and calcium into your diet.
“The beneficial effects of vitamin D and calcium supplementation have previously been shown to improve cardiovascular health, bone health and reduction in fractures due to falls in the elderly,” he noted.
Dr. Sami Saba is a neurologist at Lenox Hill Hospital in Great Neck, N.Y. He said that “the standard treatment for BPPV is a repositioning maneuver that puts the crystals in the inner ear that have been displaced back where they belong.”
However, Saba added, “the symptoms often recur after such a maneuver, and until now there hasn’t been any proven treatment to prevent recurrence.”
Vitamin D plus calcium might change all that, Saba said — and there’s logic behind the treatment.
“The inner ear crystals, or otoconia, are partially made of calcium carbonate, and vitamin D is essential for calcium metabolism, so the mechanism of the treatment makes sense,” he said.
The report was published online Aug. 5 in the journal Neurology.
More information
For more on vertigo, head to the U.S. National Library of Medicine.
SOURCES: AnthonyGeraci, MD, director, neuromuscular medicine, Northwell Health, Great Neck, N.Y.; Sami Saba, MD, neurologist, Lenox Hill Hospital, New York City; American Academy of Neurology, news release, Aug. 5, 2020
Vitamin D deficiency can cause dizziness attacks
- Health
To find out, Egyptian scientists conducted a study on 40 patients diagnosed with benign paroxysmal positional vertigo. Translated into human – dizzy with a sharp change in posture.
August 24, 2021
- Source:
- iStock/Getty Images
About 20 percent of adults complain of dizziness. Many of them are not due to problems with neurology, but with disorders in the vestibular apparatus. Calcium carbonate crystals (otoconia) enter the semicircular canals and cause benign paroxysmal positional vertigo (BPPV). It occurs most often due to a change in the position of the head, tilting, turning when you get out of bed or lie down in it. Therefore, the disease has another name – positional vertigo. It can be accompanied by mild nausea, even vomiting, and does not last long – a few minutes. Scientists have suggested that the process may be affected by a lack of vitamin D.
“We set out to evaluate the association between recurrent BPPV attacks and vitamin D deficiency,” Aida Ahmed Abdelmaqsoud, co-author of the ENT department at the University of the South Valley School of Medicine, Egypt, explained the purpose of the study in the journal Nature.
Read also
40 patients who had already been diagnosed with BPPV were selected for the study. All had low levels of vitamin D – this was a prerequisite for participation in the study. Among them were 14 men and 26 women, they were divided into two groups – receiving an additional dose of vitamin D, and those who were treated in the usual way. The therapy was repeated six months later. It was found that vitamin D directly affects the mechanism of formation of otoconial particles in the vestibular system.
“Vitamin D deficiency has been associated with BPPV severity and recurrence,” said Aida Ahmed Abdelmaqsoud. “And adding vitamin D to therapy may reduce the frequency of recurrent seizures.”
Adequate levels of vitamin D can be maintained through skin photosynthesis and oral intake. According to Egyptian scientists, about a billion people around the world suffer from a deficiency or lack of vitamin D even in summer: somewhere there is not enough sun, somewhere bad weather conditions, air pollution, too much sunscreen is used, clothes get dirty.
Text author:Alena Bezmenova
Today they read
Cardiologist Koliev named 4 habits that will not let you die of a heart attack in the prime of life
Reduce cholesterol and save from blood clots: 6 spices that every housewife should have
Personal experience : how to lower cholesterol by 35% without pills
Women over 40 are recommended to take these vitamins – the opinion of the gynecologist Volkova
Bad blood vessels and venous stasis: a vegetologist explained who suffers from stuffiness intolerance
Vitamin D and benign paroxysmal positional vertigo
PUBLICATIONS
Relevance
Benign paroxysmal positional vertigo (BPPV) is one of the most common diseases of the peripheral part of the vestibular analyzer. The main clinical manifestation of BPPV is intermittent short-term attacks of dizziness when the head position changes. It is believed that BPPV is the most common cause of dizziness (18-25% of all cases of dizziness).
Despite the benign nature of the disease, the presence of BPPV is associated with a decrease in the quality of life. However, there are no effective methods to prevent BPPV. Several observational studies have found that BPPV patients are more likely than the general population to have vitamin D deficiency and decreased bone mineral density. In this connection, the purpose of the study under discussion was to evaluate the effectiveness of vitamin D in the prevention of BPPV.
Methods
The randomized trial was performed in 8 hospitals in South Korea between December 2013 and May 2017.
Its participants were patients with BPPV. All of them were randomized into two groups: vitamin D therapy 400 IU in combination with 500 mg calcium carbonate twice a day (if the concentration of vitamin D was less than 20 ng/ml) and standard observation.
The primary end point was the annual recurrence rate. The mean follow-up period for participants was 1 year.
Results
The study participants were 1050 patients with BPPV.
It was found that, on average, during the study period, relapses of dizziness were observed with a frequency of 0.83 cases per year in the vitamin D group and 1.1 cases per year in the standard observation group (hazard ratio 0.76; 95% confidence interval 0.66-0.87; p<0.001. In addition , in the active therapy group, BPPV relapses were reported in fewer patients (37.8% vs. 46.7%; p=0.005).
The estimated number of patients who needed to be treated with vitamin D to prevent recurrence of BPPV was 3.7 (95% CI 2.5-7.14).
Conclusion
Thus, the results of the present study demonstrate that in patients with BPPV, vitamin D and calcium supplementation reduces the frequency of relapses.